
-
2009
Company Description
ProNoxis develops, produces, and markets novel treatments for autoimmune disorders.
ProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease (IBD). ProNoxis is a spin-out from Redoxis.
-
Manufacturer:
Science and Engineering -
Formed:
2009 -
Company Website:
-
Company E-mail:
-
Company Address:
Biotech Building - Plan 7, Arvid Wallgrens Backe 20GöteborgSweden -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits